JAK Inhibitors for ET and PV: What Have We Learned So Far
Автор: HMP Education
Загружено: 2016-09-12
Просмотров: 323
Описание:
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA, Dr. Ellen Ritchie discusses what we have learned thus far regarding the use of JAK inhibitors for the treatment of essential thrombocythemia (ET) and polycythemia vera (PV).
Earn accreditation for a related activity at the following location:
http://elc.imedex.com/ELC/Activity-Se...
© 2016 Imedex, LLC.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: